Fukoku Mutual Life Insurance CO Incyte Corp Transaction History

Fukoku Mutual Life Insurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	BUY	$63.34 - $74.11 $5,067 - $5,928	80 Added 3.01%	2,740 $201,000
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $26,781 - $32,767	390 Added 17.18%	2,660 $183,000
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $65,736 - $86,148	900 Added 65.69%	2,270 $198,000
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $29,127 - $34,608	400 Added 41.24%	1,370 $102,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $7,640 - $9,678	70 Added 7.78%	970 $113,000
Q2 2017 Aug 14, 2017	BUY	N/A	900	900 $113,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.